Abbott TR, Dhamdhere G, Liu Y, Lin X, Goudy, Zeng L,  Pande T (2020) Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell 181(4):865-876.e12. doi: 10.1016/j.cell.2020.04.020.

Adamo M, Lombardi CM, Metra M (2020) at a glance: focus on COVID-19, quality of life, and comorbidities. European Journal of Heart Failure 22(6):917-918. doi: 10.1002/ejhf.1515.

Agostini A, Floridi C, Borgheresi A, Badaloni M, Pirani PE, Terilli F,  Giovagnoni A (2020) Proposal of a low-dose, long-pitch, dual-source chest CT protocol on third-generation dual-source CT using a tin filter for spectral shaping at 100 kVp for CoronaVirus Disease 2019 (COVID-19) patients: a feasibility study. La Radiology Medica 125 (4): 365-373. doi: https://doi.org/10.1007/s11547-020-01179-x

Ahmad T, Haroon, Baig M, Hui J (2020a) Coronavirus Disease 2019 (COVID-19) Pandemic and Economic Impact. Pakistan Journal of Medicinal Science 36(COVID19-S4): S73-S78.

Ahmad T, Haroon, Dhama K, Sharun K, Khan FM, Ahmed I, Tiwari R, Musa TH, Khan M, Bonilla-Aldana DK, J Rodriguez-Morales A, Hui J (2020b) Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review. Turkish Journal of Biology 44(3): 132-145.

Ahuja AS, Reddy VP, Marques O (2020) Artificial intelligence and COVID-19: A multidisciplinary approach. Integrated Medicinal Research 9(3):100434. doi:10.1016/j.imr.2020.100434

Altay O, Mohammadi E, Lam S, Turkey H, Boren J, Nielsen J, Uhlen M, Mardinoglu A (2020) Current Status of COVID-19 Therapies and Drug Repositioning Applications. Iscience 23(7):101303. doi: 10.1016/j.isci.2020.101303.

Anderson DE, Cui J, Ye Q, Huang B, Zu W, Gong J, Liu W, Kim SY, Yan BG, Sigmundsson K, Lim XF, Ye F, Niu P, Zhou X, Tan W, Wang L, Tan X (2020) Orthogonal genome-wide screenings in bat cells identify MTHFD1 as a target of broad antiviral therapy. bioRxiv; 2020. DOI: 10.1101/2020.03.29.014209.

Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S (2020) COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes and Endocrinology S2213-8587(20)30238-2. doi:10.1016/S2213-8587(20)30238-2.

Araki K, Gangappa S, Dillehay DL, Rouse BT, Larsen CP, Ahmed R (2010) Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. Journal of Experimental Medicine 207(11): 2355-2367.

Arndt AL, Blake J. Larson BJ, Hogue BG (2011)  A conserved domain in the coronavirus membrane protein tail is important for virus assembly. Journal of Virology 84(21): 11418-11428. doi:10.1128/JVI.01131-10.

Arts RJW, Moorlag SJCFM, Novakovic B, Li Y, Wang SY, Oosting M, Kumar V, Xavier RJ, Wijmenga C, Joosten LAB, Reusken CBEM, Benn CS, Aaby P, Koopmans MP, Stunnenberg HG, van Crevel R, Netea MG (2018). BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe 23(1):89-100.e5. doi: 10.1016/j.chom.2017.12.010.

Arumugam VA, Thangavelu S, Fathah Z, et al. (2020) COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes. Journal of Pure and Applied Microbiology 14(3):1623-1638. doi: 10.22207/JPAM.14.3.01.

Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Madani H (2013). Hospital outbreak of Middle East respiratory syndrome coronavirus. New England Journal of Medicine 369(5): 407-416. DOI: 10.1056/NEJMoa1306742.

Avol EL, Gauderman WJ, Tan SM, London SJ, Peters JM (2001) Respiratory effects of relocating to areas of differing air pollution levels. American Journal of Respiratory and Critical Care Medicine 164(11): 2067-2072. DOI: 10.1164/rccm2102005.

Ayittey FK, Ayittey MK, Chiwero NB, Kamasah JS, Dzuvor C (2020) Economic Impacts of Wuhan 2019-nCoV on China and the World. Journal of Medical Virology 92(5): 473-475. doi: 10.1002/jmv.25706.

Bachanova V, Bishop MR, Dahi P, Dholaria B, Grupp SA, Hayes-Lattin B, Janakiram M, Maziarz RT, McGuirk JP, Nastoupil LJ, Oluwole OO, Perales MA, Porter DL, Riedell PA (2020) CAR T-cell Consortium. Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biology of Blood and Marrow Transplantation 26(7):1239-1246. doi: 10.1016/j.bbmt.2020.04.008.

Baradaran A, Ebrahimzadeh MH, Baradaran A, Kachooei AR (2020) Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis. The Archives of Bone and joint surgery 8(Suppl 1):247-255. doi:10.22038/abjs.2020.47754.2346

Baranov PV, Henderson CM, Anderson CB, Gesteland RF, Atkins JF, Howard, MT (2005) Programmed ribosomal frame shifting in decoding the SARS-CoV genome. Virology 332(2), 498-510.

Barbuddhe SB, Rawool DB, Gaonkar PP, Vergis J, Dhama K, Malik SS (2020) Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic. Human Vaccines and Immunotherapeutics 16(12): doi: 10.1080/21645515.2020.1810496.

Bárcena M, Oostergetel GT, Bartelink W, Faas FG, Verkleij A, Rottier PJ Bosch BJ (2009) Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the corona vision. Proceedings of the National Academy of Sciences 106(2): 582-587.

Beelen R, Hoek G, van Den Brandt PA, Goldbohm RA, Fischer P, Schouten LJ, Brunekreef B (2008) Long-term effects of traffic-related air pollution on mortality in a Dutch cohort (NLCS-AIR study). Environmental Health Perspectives 116(2): 196-202.

Belouzard S, Chu VC, Whittaker GR (2009) Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proceedings of the National Academy of Sciences 106(14): 5871-5876.

Beniac DR, Andonov A, Grudeski E, Booth TF (2006). The architecture of the SARS coronavirus prefusion spike. Nature Structural & Molecular Biology 13(8): 751-752.

Bilal M, Iqbal HM (2020) Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2. Human Vaccines & Immunotherapeutics, 1-9. DOI: https://doi.org/10.1080/21645515.2020.1794685.

Bilal M, Nazir MS, Ahmed I, Iqbal H (2020b) Coronaviruses and COVID-19–Complications and Lessons Learned for the Future. Journal of Pure and Applied Microbiology 1(14): 725-731, 20200416.

Bilal M, Nazir MS, Parra-Saldivar R, Iqbal HM (2020a) ncov/covid-19-approaches to viral vaccine development and preventive measures. Journal of Pure and Applied Microbiology 14(1): 25-29.

Bilal M, Nazir MS, Rasheed T, Parra-Saldivar R, Iqbal HM (2020c) Water matrices as potential source of SARS-CoV-2 transmission–An overview from environmental perspective. Case Studies in Chemical and Environmental Engineering, 100023.DOI: https://doi.org/10.1016/j.cscee.2020.100023.

Blomberg A, Krishna, MT, Helleday R, Soderberg M, Ledin MC, Kelly FJ, Sandstrom T (1999). Persistent airway inflammation but accommodated antioxidant and lung function responses after repeated daily exposure to nitrogen dioxide. American Journal of Respiratory and Critical Care Medicine 159(2): 536-543.

Bonilla-Aldana DK, Dhama K, Rodriguez-Morales AJ (2020) Revisiting the One Health Approach in the Context of COVID-19: A look into the Ecology of this Emerging Disease. Advances in Animal and Veterinary Sciences 8(3):234-237.

Boscarino JA, Logan HL, Lacny JJ, Gallagher TM (2008) Envelope protein palmitoylations are crucial for murine coronavirus assembly. Journal of Virology 82: 2989-2999.

Bosch BJ, van der Zee R, de Haan CA, Rottier PJ (2003) The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. Journal of Virology 77(16):8801-8811.

Bowatte G, Erbas B, Lodge CJ, Knibbs LD, Gurrin LC, Marks GB, Dennekamp M (2017) Traffic-related air pollution exposure over a 5-year period is associated with an increased risk of asthma and poor lung function in middle age. European Respiratory Journal 50(4): 1602357.

Braun J, Loyal L, Frentsch M, Wendisch D, Georg P, Kurth F, Hippenstiel S, Dingeldey M, Kruse B, Fauchere F, Baysal E, Mangold M, Henze L, Lauster R, Mall MA, Beyer K, Röhmel J, Voigt S, Schmitz J, Miltenyi S, Demuth I, Müller MA, Hocke A, Witzenrath M, Suttorp N, Kern F, Reimer U, Wenschuh H, Drosten C, Corman VM, Giesecke-Thiel C, Sander LE, Thiel A (2020) SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. doi: 10.1038/s41586-020-2598-9.

Brierley I, Digard P, Inglis, SC (1989) Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot. Cell 57(4): 537-547. https://doi.org/10.1016/0092-8674(89)90124-4.

Brown CG, Nixon KS, Senanayake SD, Brian DA (2007) An RNA stem-loop within the bovine coronavirus nsp1 coding region is a cis-acting element in defective interfering RNA replication. Journal of Virology 81(14): 7716-7724.

Caccamo N, Sullivan LC, Brooks AG, Dieli F (2020) Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID-19. British Journal of Haematology DOI: 1:10.1111/bjh.16895. doi: 10.1111/bjh.16895.

Caly L, Druce JD, Catton MG, Jans DA, Wagstaff  KM (2020) The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research 178:104787. doi: 10.1016/Journal of Antiviral Research 2020.104787.

Casadevall A, Pirofski LA (2020) The convalescent sera option for containing COVID-19. Journal of Clinical Investigation 4: 1545-1548. https://doi.org/10.1172/JCI138003.

Chen L, Hu C, Hood M, Zhang X, Zhang L, Kan J, Du J (2020c) A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis. Nutrients 12(4):1193. doi: 10.3390/nu12041

Chen L, Xiong J, Bao L, Shi Y (2020b) Convalescent plasma as a potential therapy for COVID-19. The Lancet Infectious Diseases 20(4):398-400. doi:10.1016/S1473-3099(20)30141-9

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Yu T (2020a) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 395(10223): 507-513.

Chen TM, Kuschner WG, Gokhale J, Shofer S (2007) Outdoor air pollution: nitrogen dioxide, sulfur dioxide, and carbon monoxide health effects. The American Journal of the Medical Sciences 333(4): 249-256.

Chen X, Hu W, Ling J, Mo P, Zhang Y, Jiang Q, Ma Z, Cao Q, Deng L, Song S, et al: (2020d) Hypertension and Diabetes Delay the Viral Clearance in COVID-19 Patients. medRxiv. 2020.2003.2022.20040774.

Chen Y, Liu Q,  Guo D (2020e) Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of Medical Virology 92(4): 418-423. Doi: 10.1002/jmv.25681

Cheng PK, Wong DA, Tong LK, Ip SM, Lo AC, Lau CS, Lim WW (2004) Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. The Lancet 363(9422): 1699-1700.

Choy KT, Wong AY, Kaewpreedee P, Sia SF, Chen D, Hui KPY, Chu DKW, Chan MCW, Cheung PP, Huang X, Peiris M, Yen HL (2020) Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Research 178:104786. doi: 10.1016/j.antiviral.2020.104786.

Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, El-harakeh A, Bognanni A, Lotfi T, Loeb M, Hajizadeh A (2020) Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. The Lancet  395: ISSUE 10242, P1973-1987, doi.org/10.1016/S0140-6736(20)31142-9

Chu DK, Poon LL, Gomaa MM, Shehata MM, Perera RA, Zeid DA, El Rifay AS, Siu LY, Guan Y, Webby RJ, Ali MA (2014) MERS coronaviruses in dromedary camels, Egypt. Emerging Infectious Diseases 20(6):1049.

Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S (2020) The COVID-19 pandemic. Critical Reviews in Clinical Laboratory Sciences 57(6):365-388.

Cornelissen LA, Wierda CM, Van Der Meer FJ, Herrewegh AA, Horzinek, MC, Egberink HF, De Groot, RJ (1997) Hemagglutinin-esterase, a novel structural protein of torovirus. Journal of Virology 71(7): 5277-5286.

Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology 17(3): 181-192.

de Groot RJ, Baker SC, Ralph RS, Brown CS, Drosten C, Enjuanes L, et al. (2013) Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group Journal of Virology 87(14): 7790–7792.

De Hanan CA, Kuo L. Master PS, Vennema H, Rottier PJ (1998) Coronavirus particle assembly: primary structure requirement of the membrane protein. Journal of Virology 72:6838-6850.

Delmas BERNARD, Laude H U B E R T (1990) Assembly of coronavirus spike protein into trimers and its role in epitope expression. Journal of Virology 64(11): 5367-5375.

Devaux CA, Rolain JM, Colson P, Raoult D (2020) New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? International Journal of Antimicrobial Agents 55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938.

Dhama K, Karthik K, Khandia R, Munjal A, Tiwari R, Rana R, Khurana SK, Sana Ullah, Khan RU, Alagawany M, Farag MR, Dadar M, Joshi SK (2018) Medicinal and therapeutic potential of herbs and plant metabolites/extracts countering viral pathogens - Current knowledge and future prospects. Current Drug Metabolism 19(3):236-263. doi: 10.2174/1389200219666180129145252.

Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020a) Coronavirus Disease 2019-COVID-19. Clinical Microbiology Reviews 33(4):e00028-20.

Dhama K, Patel SK, Pathak M, Yatoo MI, Tiwari R, Malik YS, Singh R, Sah R, Rabaan AA, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020b) An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Medicine and Infectious Disease 101755.

Dhama K, Saminathan M, Jacob SS, Singh M, Karthik K, Amarpal, Tiwari R, Sunkara LT, Malik YS, Singh RK (2015) Effect of immunomodulation and immunomodulatory agents on health with some bioactive principles, modes of action, and potent biomedical applications. International Journal of Pharmacolology 11(4): 253-290.

Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W (2020c) COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Human Vaccines and Immuno therapeutics 16(6):1232-1238.

Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, et al. (2020) Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of National Academy of Sciences USA 117(17): 9490-9496. doi: 10.1073/pnas.2004168117.

Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. In Coronaviruses (pp. 1-23). Humana Press, New York, NY.

Felsenstein S, Herbert JA, McNamara PS, Hedrich CM (2020) COVID-19: Immunology and treatment options. Clinical Immunology 2020;215:108448. doi:10.1016/j.clim.2020.108448.

Fu B, Xu X, Wei H (2020) Why tocilizumab could be an effective treatment for severe COVID-19? Journal of Translational Medicine 18(1):164. doi: 10.1186/s12967-020-02339-3.

Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L (2020) Acute kidney injury in critically ill patients with COVID-19. Intensive Care Medicine. doi: 10.1007/s00134-020-06153-9.

Galanakis CM (2020) The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis. Foods 4: 523. https://doi.org/10.3390/foods9040523.

Gan WQ, Davies HW, Koehoorn M, Brauer M (2012) Association of long-term exposure to community noise and traffic-related air pollution with coronary heart disease mortality. American Journal of Epidemiology 175(9): 898-906.

Gangal N, Nagle V,  Pawar Y,  Dasgupta S (2020) Reconsidering Traditional Medicinal Plants to Combat COVID-19. AIJR Preprints 2020; https://preprints.aijr.org/index.php/ap/preprint/view/34.

Gao J, Tian Z, Yang X (2020) Breakthrough: Chloroquine phosphate has shown apparent efficacy in the treatment of COVID-19 associated pneumonia in clinical studies. Bio Science Trends 14(1):72-73. doi: 10.5582/bst.2020.01047.

Gassen NC, Niemeyer D, Muth D, Corman VM, Martinelli S, Gassen A, Hafner K, Papies J, Mösbauer K, Zellner A, Zannas AS, Herrmann A, Holsboer F, Brack-Werner R, Boshart M, Müller-Myhsok B, Drosten C, Müller MA, Rein T (2019) SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection. Nature Communications 10(1):5770. doi: 10.1038/s41467-019-13659-4.

Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Zhang YJ (2013) Isolation and characterization of a bat SARS-like coronavirus that uses the ACE-2 receptor. Nature 503(7477): 535-538.

Giacca M, Bussani R, Schneider E, Zentilin L, Collesi C, Ali H, Braga L, Secco I, Volpe MC, Colliva A, Zanconati F (2020) Persistence of viral RNA, widespread thrombosis and abnormal cellular syncytia are hallmarks of COVID-19 lung pathology. medRxiv. 2020 Jan 1.

Golonka RM, Saha P, Yeoh BS, Chattopadhyay S, Gewirtz AT, Joe B, Vijay-Kumar M (2020) Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease. Physiological Genomics 52(5):217-221. doi: 10.1152/physiolgenomics.00033.2020.

Guan BJ, Wu HY,  Brian DA (2011) An optimal cis-replication stem-loop IV in the 5′ untranslated region of the mouse coronavirus genome extends 16 nucleotides into open reading frame 1. Journal of Virology 85(11): 5593-5605.

Guan WJ, Chen RC, Zhong NS (2020b) Strategies for the prevention and management of coronavirus disease in 2019. European Respiratory Journal 55(4):2000597. doi:10.1183/13993003.00597-2020

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Du B (2020a) Clinical characteristics of coronavirus disease in 2019 in China. New England Journal of Medicine 382(18):1708-1720.

Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, Butt KM (2003) Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302(5643):276-8.

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Yan Y (2020) The origin, transmission, and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research 7(1): 1-10.

Gupta A (2020) Is Immuno-modulation the Key to COVID-19 Pandemic?. Indian Journal of Orthopaedics, 27: 1-4.

Guy RK, Di Paola RS, Romanelli F, Dutch RE (2020) Rapid repurposing of drugs for COVID-19. Science 368(6493):829-830. doi: 10.1126/science.abb9332.

Halpin DMG, Singh D, Hadfield RM (2020) Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. European Respiratory Journal 55(5):2001009. doi: 10.1183/13993003.01009-2020.

Henry BM, Lippi G (2020) chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International Urology and Nephrology 52(6):1193-1194. Doi: 10.1007/s11255-020-02451-9.

Hoek G, Krishnan RM, Beelen R, Peters A, Ostro B, Brunekreef B, Kaufman JD (2013) Long-term air pollution exposure and cardio-respiratory mortality: a review. Environmental Health 12(1): 43.

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK (2020) Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine 382(10):929-936. doi: 10.1056/NEJMoa2001191.

https://www.worldometers.info/coronavirus/. Accessed on 13^th November, 2020.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Cheng Z (2020b) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395(10223): 497-506.

Huang Y, Tu M, Wang S, Chen S, Zhou W, Chen D, Zhou L, Wang M, Zhao Y, Zeng W, Huang Q (2020a) Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel Medicine and Infectious Disease 36:101606.  doi: 10.1016/j.tmaid.2020.101606.

Huang Y, Yang C, Xu XF, Xu W, Liu SW (2020c) Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica 41(9):1141-1149. doi: 10.1038/s41401-020-0485-4.

Hurst KR, Koetzner CA, Masters PS (2009) Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein. Journal of Virology 83(14): 7221-7234.

Hurst KR, Koetzner CA, Masters PS (2013) Characterization of a critical interaction between the coronavirus nucleocapsid protein and non structural protein 3 of the viral replicase-transcriptase complex. Journal of Virology 87(16): 9159-9172.

Ianevski A, Yao R, Fenstad MH, Biza S, Zusinaite E, Reisberg T, Lysvand H, Løseth K, Landsem VM, Malmring JF, Oksenych V, Erlandsen SE, Aas PA, Hagen L, Pettersen CH, Tenson T, Afset JE, Nordbø SA, Bjørås M, Kainov DE (2020) Potential Antiviral Options against SARS-CoV-2 Infection. Viruses 12(6):642. doi: 10.3390/v12060642.

Ihsanullah I, Bilal M, Naushad M (2020) Coronavirus 2 (SARS-CoV-2) in water environments: Current status, challenges and research opportunities. Journal of Water Process Engineering 101735.

Infusino F, Marazzato M, Mancone M, Fedele F, Mastroianni CM, Severino P, Ceccarelli G, Santinelli L, Cavarretta E, Marullo AGM, Miraldi F, Carnevale R, Nocella C, Biondi-Zoccai G, Pagnini C, Schiavon S, Pugliese F, Frati G, d'Ettorre G (2020) Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review. Nutrients 12(6):E1718. doi: 10.3390/nu12061718.

Iwabuchi K, Yoshie K, Kurakami Y, Takahashi K, Kato Y, Morishima T (2020) Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases. Journal of infection and chemotherapy 26(6):625-632. doi: 10.1016/j.jiac.2020.04.007.

Jaggers GK, Watkins BA, Rodriguez RL (2020) COVID-19: Repositioning nutrition research for the next pandemic. Nutrition Research doi: 10.1016/j.nutres.2020.07.005.

Jahan I, Onay A (2020) Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turkish Journal of Biology 44(3):228-241. doi: 10.3906/biy-2005-114.

Jahanshahlu L, Rezaei N (2020) Monoclonal antibody as a potential anti-COVID-19. Biomedicne and Pharmacotherapy 129:110337. doi: 10.1016/j.biopha.2020.110337.

James-Gauderman, W, McConnell ROB, Gilliland F, London S, Thomas D, Avol E, Margolis HG (2000) Association between air pollution and lung function growth in southern California children. American Journal of Respiratory and Critical Care Medicine 162(4): 1383-1390.

Jang CH, Choi JH, Byun MS, Jue DM (2006) Chloroquine inhibits the production of TNF-alpha, IL-1beta, and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes. Rheumatology (Oxford) 45(6):703-10. doi: 10.1093/rheumatology/kei282.

Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P (2020) Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 14(4):367-382. doi: 10.1016/j.dsx.2020.04.015.

Jeon S, Ko M, Lee J, Choi I, Byun SY, Park S, Shum D, Kim S (2020) Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. Antimicrobial Agents and Chemotherapy 64(7):e00819-20. doi: 10.1128/AAC.00819-20.

Kazi L, Lissenberg A, Watson R, de Groot RJ, Weiss SR (2005) Expression of hemagglutinin esterase protein from the recombinant mouse hepatitis virus enhances Neuro virulence. Journal of Virology 79(24): 15064-15073.

Keam S, Megawati D, Patel SK, Tiwari R, Dhama K, Harapan H (2020) Immunopathology, and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infections. Reviews in Medical Virology 10.1002/rmv.2123. doi:10.1002/rmv.2123.

Keni R, Alexander A, Nayak PG, Mudgal J, Nandakumar K (2020) COVID-19: Emergence, Spread, Possible Treatments, and Global Burden. Frontiers in Public Health 8: 216.

Khoder MI (2002) Atmospheric conversion of sulfur dioxide to particulate sulfate and nitrogen dioxide to particulate nitrate and gaseous nitric acid in an urban area. Chemosphere 49(6): 675-684.

Kubo H, Yamada YK, Taguchi F (1994) Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. Journal of Virology 68(9): 5403-5410.

Kumar GV, Jeyanthi V, Ramakrishnan S (2020) A short review on antibody therapy for COVID-19. New Microbes and New Infections 35: 100682. https://doi.org/10.1016/j.nmni.2020.100682.

Kuo L, Masters PS (2013) Functional analysis of the murine coronavirus genomic RNA packaging signal. Journal of Virology 87(9): 5182-5192.

Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, Wong SS, Leung SY, Chan KH, Yuen KY (2005) severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proceedings of the National Academy of Sciences 102(39):14040-5.

Laura Riva, Shuofeng Yuan, Xin Yin, Laura Martin-Sancho, et al. (2020) Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature https://doi.org/10.1038/s41586-020-2577-1

Ledford H (2020) Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature 582(7813):469. doi: 10.1038/d41586-020-01824-5.

Lei Zha,  Shirong Li, Lingling Pan, Boris Tefsen, Yeshan  Li, Neil  French, et al., (2020)  Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). The Medicinal Journal of Australia 212 (9): 416-420.

Lenzen M, Li M, Malik A, Pomponi F, Sun YY, Wiedmann T, Faturay F, Fry J, Gallego B, Geschke A, Gómez-Paredes J, Kanemoto K, Kenway S, Nansai K, Prokopenko M, Wakiyama T, Wang Y, Yousefzadeh M (2020) Global socio-economic losses and environmental gains from the Coronavirus pandemic. PLoS One 15(7):e0235654.

Letko M, Marzi A, Munster V (2020) Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B beta coronaviruses. Nature microbiology 5(4):562-569.

Li C, Wang L, Ren L (2020c) Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection. Virus Research 286:198073.

Li F (2015) Receptor recognition mechanisms of coronaviruses: A decade of structural studies. Journal of Virology 89(4): 1954-1964.

Li F, Li W, Farzan M, Harrison SC (2005) Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309: 1864-1868;

Li L, Gong S, Yan J (2020b) Clinical observation and management of COVID-19 patients. Journal of Emerging Microbes & Infections 9(1):687-690.

Li X, Song Y, Wong G, Cui J (2020a) Bat origin of a new human coronavirus: there and back again. Science China Life Sciences 63(3): 461-462.

Li Y, Liu X, Guo L, Li J, Zhong D, Zhang Y, Clarke M, Jin R (2020d) Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis. Systematic Reviews 9(1):75. doi: 10.1186/s13643-020-01343-4.      

Liang B, Chen J, Li T, Wu H, Yang W, Li Y (2020) Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells. Medicine (Baltimore)  99(31):e21429.

Lipworth B, Kuo CR, Lipworth S, Chan R (2020) Inhaled Corticosteroids and COVID-19. American Journal of Respiratory Critical Care Medicine doi: 10.1164/rccm.202005-2000LE.

Lissenberg A, Vrolijk MM, van Vliet AL, Langereis MA, de Groot-Mijnes JD, Rottier PJ, de Groot RJ (2005) Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro. Journal of Virology 79(24):15054-63. doi: 10.1128/JVI.79.24.15054-15063.2005.

Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Zhong W, Wang M (2020a) Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery 6:16. doi: 10.1038/s41421-020-0156-0.

Liu P, Chen W, Chen JP (2019) Viral metagenomics revealed Sendai virus and coronavirus infection of Malayan pangolins (Manis javanica). Viruses 11(11):979.

Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou, L, Ming Y (2020b). Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Medical Journal.

Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, Zhang Y, Zhang W, Yuan Y, Bao J (2013) Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.